We are comparing two medications to see which one may reduce the risk of hernias after simultaneous pancreas and kidney transplants in people with type 1 diabetes. We also want to understand their effects on diabetes complications.
Health conditions and diseases that the clinical trial is designed to study and treat.
End-stage kidney disease in Type 1 diabetes occurs when the kidneys can no longer function effectively due to damage caused by prolonged high blood sugar levels, leading to the need for dialysis or a kidney transplant.
Transplantation complications refer to various health issues that can arise after an organ transplant, including rejection of the organ, infections, and complications related to medications used to prevent rejection.
Simultaneous pancreas and kidney transplantation is a surgical procedure where both a kidney and a pancreas are transplanted at the same time, often performed on patients with Type 1 diabetes to improve blood sugar control and kidney function.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.